Neural stemness unifies cell tumorigenicity and pluripotent differentiation potential

Area of Science:

• Stem cell biology
• Cancer research
• Epigenetics

Background:

• Neural stemness is proposed as a fundamental state underlying tumorigenicity and pluripotent differentiation.
• The precise relationship between neural stemness, tumorigenicity, and differentiation potential remains unclear.
• SET domain bifurcated transcription factor 1 (SETDB1) is an oncoprotein highly expressed in embryonic neural cells.

Purpose of the Study:

• To investigate the coupled relationship between neural stemness, tumorigenicity, and pluripotent differentiation potential.
• To elucidate the role of SETDB1 in maintaining neural stemness and its impact on cancer cell properties.
• To identify the molecular mechanisms linking neural stemness to cellular proliferation and differentiation.

Main Methods:

• Disruption of neural regulatory networks in neural stem and cancer cells.
• Serial transplantation of cancer cells to assess tumorigenicity and differentiation.
• Manipulation of SETDB1 expression (inhibition and overexpression) and analysis of downstream targets.

Main Results:

• Loss of neural stemness via SETDB1 inhibition led to neuronal differentiation, reduced tumorigenicity, and decreased pluripotent potential.
• SETDB1 overexpression enhanced neural stemness, increasing tumorigenicity and pluripotent differentiation potential.
• SETDB1 maintains a regulatory network involving epigenetic modifiers, ribosome biogenesis, translation, and spliceosome proteins, crucial for proliferation and pluripotency.

Conclusions:

• Neural stemness unifies tumorigenicity and pluripotent differentiation potential, acting as a central regulatory state.
• SETDB1 is a key regulator of neural stemness, controlling a network of proteins essential for developmental programs and cellular machinery.
• These findings suggest that targeting SETDB1 could offer new therapeutic strategies for cancers by modulating stemness and differentiation.